About Prime Genomics
Prime Genomics is a company based in San Francisco (United States) founded in 2010 by Sandy Shaw. It operates as a B2B. Prime Genomics has raised $1.02 million across 5 funding rounds from investors including HHS and Iron Yard Ventures. Prime Genomics operates in a competitive market with competitors including Inflammatix, Agendia, PathogenDX, PreludeDx and Miltel, among others.
- Headquarter San Francisco, United States
- Founders Sandy Shaw
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.02 M (USD)
in 5 rounds
-
Latest Funding Round
$460.15 K (USD), Grant
Jun 03, 2021
-
Investors
HHS
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Prime Genomics
Prime Genomics has successfully raised a total of $1.02M across 5 strategic funding rounds. The most recent funding activity was a Grant round of $460.15 thousand completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Grant — $460,152
-
First Round
First Round
(27 Dec 2011)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2021 | Amount | Grant - Prime Genomics | Valuation |
investors |
|
| Apr, 2019 | Amount | Grant - Prime Genomics | Valuation |
investors |
|
| Dec, 2014 | Amount | Seed - Prime Genomics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Prime Genomics
Prime Genomics has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS and Iron Yard Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Accelerator & VC firm investing in seed & early stage tech and life sciences companies in the US
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Prime Genomics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Prime Genomics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Prime Genomics Comparisons
Competitors of Prime Genomics
Prime Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inflammatix, Agendia, PathogenDX, PreludeDx and Miltel, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of diagnostic solutions for systemic infections
|
|
| domain | founded_year | HQ Location |
Genomic diagnostic products for cancer treatment are provided.
|
|
| domain | founded_year | HQ Location |
Provider of DNA-based pathogen testing kits
|
|
| domain | founded_year | HQ Location |
Risk assessment tests for early-stage breast cancer are provided.
|
|
| domain | founded_year | HQ Location |
Telomere tests for aging detection and cellular senescence are provided.
|
|
| domain | founded_year | HQ Location |
Provider of technologies for multiplex and simultaneous analysis of biological systems at the cell, protein, and gene level
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Prime Genomics
When was Prime Genomics founded?
Prime Genomics was founded in 2010 and raised its 1st funding round 1 year after it was founded.
Where is Prime Genomics located?
Prime Genomics is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Is Prime Genomics a funded company?
Prime Genomics is a funded company, having raised a total of $1.02M across 5 funding rounds to date. The company's 1st funding round was a Seed of $803.6K, raised on Dec 27, 2011.
What does Prime Genomics do?
Prime Genomics operates with a B2B model, focusing on providing healthcare solutions, advancing biotech innovations, offering diagnostic solutions, and cancer screening. Provides breast cancer diagnostics using non-invasive saliva samples. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
Who are the top competitors of Prime Genomics?
Prime Genomics's top competitors include Inflammatix, PathogenDX and Agendia.
Who are Prime Genomics's investors?
Prime Genomics has 2 investors. Key investors include HHS, and Iron Yard Ventures.